Europe Pregnancy and Fertility Testing Market: By Product Type (Pregnancy Test Kits (Strips/Dip Sticks, Midstream Kits, Card or Cassette Kits, and Digital Devices) Fertility/Ovulation Test Kits (Line Indicator Devices and Digital Devices)), By Test Type (HCG Urine Test, HCG Blood Test, FSH Urine Test, and LH Urine Test) By End User (Hospitals, Clinics, Homecare, and Diagnostics Centers), and Country (Germany, France, U.K, Italy, Spain, Russia, Poland, and Rest of Europe) - Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

October 2017 | 104 pages | ID: E078B954CE8EN
Precision Business Insights (PBI)

Abstracts

Europe Pregnancy and Fertility Testing Market Report Description:

Europe pregnancy and fertility testing market report gives comprehensive outlook on pregnancy and fertility testing across the region with special emphasis on key countries such as Germany, France, U.K, Italy, Spain, Russia, and Poland. The report on pregnancy and fertility testing market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, test type, end users, and country. Europe pregnancy and fertility testing market report presents the market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Europe pregnancy and fertility testing market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Europe pregnancy and fertility testing market to better equip clients with possible investment opportunities across the countries (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Europe pregnancy and fertility testing market report include component suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers, who are engaged in usage and advocacy of pregnancy and fertility testing.

Europe Pregnancy and Fertility Testing Market:

Europe Pregnancy and Fertility Testing market was valued around US$ 260 Mn in 2016 and poised to grow around 4.5% CAGR over 2017-2023.

COMPETITION ASSESSMENT

Key players profiles in the Europe pregnancy and fertility testing market include:

• Abbott Laboratories
• Alere Inc.
• bioMérieux SA
• Church & Dwight Co., Inc.
• DCC Plc.
• Geratherm Medical AG
• Germaine Laboratories
• Kent Pharmaceuticals
• Prestige Brands Holdings
• Procter & Gamble Co.
• Quidel Corporation
• Rite-Aid
• Swiss Precision Diagnostics GmbH

Players in the Europe Pregnancy and Fertility Testing market are entering into partnerships and collaborations, launching newer products in the market to garner larger market share

KEY FEATURES OF THE REPORT:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The Report Outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

DETAILED SEGMENTATION

By Product Type

• Pregnancy Test Kits
• Strips/Dip Sticks
• Midstream Kits
• Card or Cassette Kits
• Digital Devices
• Fertility/Ovulation Test Kits
• Line Indicator Devices
• Digital Devices

By Test Type

• HCG Urine Test
• HCG Blood Test
• FSH Urine Test
• LH Urine Test

By End User

• Hospitals
• Clinics
• Homecare
• Diagnostics Centers

Country

• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

Contents

1. EXECUTIVE SUMMARY

2. EUROPE PREGNANCY AND FERTILITY TESTING MARKET INTRODUCTION

2.1. Europe Pregnancy and Fertility Testing Market – Taxonomy
2.2. Europe Pregnancy and Fertility Testing Market –Definitions
  2.2.1. Product Type
  2.2.2. Test type
  2.2.3. End-user

3. EUROPE PREGNANCY AND FERTILITY TESTING MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Europe Pregnancy and Fertility Testing Market Dynamics – Factors Impact Analysis
3.6. Europe Pregnancy and Fertility Testing Market – Regulations
3.7. Europe Pregnancy and Fertility Testing Market – Product Innovations

4. EUROPE PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. EUROPE PREGNANCY AND FERTILITY TESTING MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Pregnancy Test Kits
  5.1.1. Strips/Dip Sticks
  5.1.2. Midstream Kits
  5.1.3. Card or Cassette Kits
  5.1.4. Digital Devices
5.2. Fertility/Ovulation Test Kits
  5.2.1. Line Indicator Devices
  5.2.2. Digital Devices

6. EUROPE PREGNANCY AND FERTILITY TESTING MARKET FORECAST, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. HCG Urine Test
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. HCG Blood Test
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis
6.3. FSH Urine Test
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.3.3. Market Opportunity Analysis
6.4. LH Urine Test
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.5.3. Market Opportunity Analysis

7. EUROPE PREGNANCY AND FERTILITY TESTING MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Hospitals
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Clinics
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Diagnostics Centers
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis
7.4. Homecare
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.4.3. Market Opportunity Analysis

8. EUROPE PREGNANCY AND FERTILITY TESTING MARKET FORECAST, BY COUNTRY, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Germany
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.1.3. Market Opportunity Analysis
8.2. France
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.2.3. Market Opportunity Analysis
8.3. U.K
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.3.3. Market Opportunity Analysis
8.4. Italy
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.4.3. Market Opportunity Analysis
8.5. Spain
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.5.3. Market Opportunity Analysis
8.6. Russia
  8.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.6.3. Market Opportunity Analysis
8.7. Poland
  8.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.7.3. Market Opportunity Analysis
8.8. Rest of Europe
  8.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.8.3. Market Opportunity Analysis
8.9. Europe Pregnancy and Fertility Testing Market - Opportunity Analysis Index, By Product Type, Application, End-User and Region, 2017 – 2023

9. GERMANY PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.2. Pregnancy Test Kits
    9.1.2.1. Strips/Dip Sticks
    9.1.2.2. Midstream Kits
    9.1.2.3. Card or Cassette Kits
    9.1.2.4. Digital Devices
  9.1.3. Fertility/Ovulation Test Kits
    9.1.3.1. Line Indicator Devices
    9.1.3.2. Digital Devices
  9.1.4. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.4.1. HCG Urine Test
    9.1.4.2. HCG Blood Test
    9.1.4.3. FSH Urine Test
    9.1.4.4. LH Urine Test
    9.1.4.5. Others
  9.1.5. End-user Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.5.1. Hospitals
    9.1.5.2. Clinics
    9.1.5.3. Diagnostic Centers
    9.1.5.4. Homecare
  9.1.6. Europe Pregnancy and Fertility Testing Market - Opportunity Analysis Index, By Product Type, Test type, demographics and Country, 2017 – 2023
  9.1.7. Europe Pregnancy and Fertility Testing Market Dynamics – Trends

10. UK PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

11. FRANCE PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

12. SPAIN PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

13. ITALY PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

14. RUSSIA PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

15. POLAND PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

16. OTHERS PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

17. COMPETITION LANDSCAPE

17.1. Strategic Dashboard of Top Market Players
17.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  17.2.1. Abbott Laboratories
  17.2.2. Alere Inc.
  17.2.3. bioMérieux SA
  17.2.4. Church & Dwight Co., Inc.
  17.2.5. DCC Plc.
  17.2.6. Geratherm Medical AG
  17.2.7. Germaine Laboratories
  17.2.8. Kent Pharmaceuticals
  17.2.9. Prestige Brands Holdings
  17.2.10. Procter & Gamble Co.
  17.2.11. Quidel Corporation
  17.2.12. Rite-Aid
  17.2.13. Swiss Precision Diagnostics GmbH

18. RESEARCH METHODOLOGY

19. KEY ASSUMPTIONS AND ACRONYMS